Bullous Keratopathy: Symptoms, Causes, and Treatment
Understanding Bullous Keratopathy
To understand this condition, it helps to know how the cornea (the clear front surface of the eye) normally works and what goes wrong when it fails. The cornea must stay clear for light to pass through and reach the back of the eye where vision is processed.
The innermost layer of the cornea is called the endothelium. It is made up of specialized pump cells whose job is to continuously remove fluid from the cornea, keeping it thin and transparent. We are born with a fixed number of these cells, and they do not regenerate when they are lost.
When enough pump cells die off, the cornea can no longer drain fluid properly. Fluid builds up inside the corneal tissue, causing it to thicken, swell, and turn cloudy. This swelling is called corneal edema, and it is the defining feature of bullous keratopathy.
As fluid continues to accumulate, it eventually works its way to the surface of the cornea and forms small fluid-filled blisters called bullae. These blisters sit on the outermost layer of the cornea and are what give the condition its name.
When a blister breaks open, the nerves just beneath the corneal surface become directly exposed to air, tears, and blinking eyelids. This exposure causes sudden, intense, stabbing pain that can last for hours until the surface begins to heal over again.
The earliest and most recognizable symptom is blurry vision that is worse in the morning. During sleep, the eyelids are closed and the eye cannot release moisture, so fluid accumulates overnight. Vision may improve somewhat as the day goes on and the eye is open to the air.
As the condition progresses, symptoms become more persistent and more difficult to manage. These can include:
- Constant blurry or hazy vision that does not clear up during the day
- Sharp, sudden eye pain when a blister ruptures
- Sensitivity to light
- A persistent foreign-body sensation, as if something is in the eye
- Excessive tearing
- Redness of the eye
If you are experiencing any of these symptoms, an evaluation with a Cornea Specialist can help determine the cause and the best course of action.
What Causes Bullous Keratopathy
Bullous keratopathy is not a disease in itself but rather the result of endothelial cell failure. Several underlying conditions and events can lead to this failure, and identifying the cause shapes how treatment is approached.
Fuchs endothelial dystrophy is an inherited condition that causes the endothelial pump cells to slowly deteriorate over time. It is one of the most common causes of bullous keratopathy and typically becomes symptomatic in middle age or later.
Because Fuchs often runs in families, a Cornea Specialist may detect early signs of it during a routine eye exam, well before bullous keratopathy develops. When caught early, salt-based eye drops and regular monitoring can help manage the condition and delay progression.
Cataract surgery is one of the most common causes of bullous keratopathy. During surgery, the natural lens of the eye is removed and replaced with an artificial lens implant (called a pseudophakic lens). In some cases, the pump cells can be damaged during the procedure, particularly in eyes that are anatomically complex, have shallow chambers, or require removal of a very dense cataract.
This is referred to as pseudophakic bullous keratopathy. Modern surgical techniques and technology have greatly reduced this risk, but it remains a recognized complication. If you notice persistent cloudiness or morning blur after cataract surgery, it is important to let your doctor know promptly.
A significant injury to the eye can directly damage or destroy endothelial cells. Because these cells do not regenerate, even a single traumatic event can set the stage for long-term corneal swelling.
Repeated eye surgeries, even successful ones, can accumulate stress on the endothelium over time. Prior surgeries for glaucoma, retinal disease, or other conditions can each contribute to gradual cell loss. Your Cornea Specialist can track your endothelial cell count using a painless imaging test called specular microscopy and monitor changes over time.
Less commonly, conditions such as herpes simplex eye disease (a viral infection of the cornea) or viral uveitis (inflammation inside the eye) can inflame and destroy endothelial cells. Chronically elevated eye pressure from poorly controlled glaucoma can also damage the endothelium over time.
Each of these causes requires its own management strategy, and treating the underlying condition when possible is always an important part of the care plan.
Non-Surgical Treatment Options
Not every patient with bullous keratopathy needs immediate surgery. Several approaches can reduce discomfort and help manage the condition, particularly in earlier stages or when a patient is not yet a surgical candidate.
Hypertonic saline eye drops and ointments are a common first-line treatment. These solutions draw excess fluid out of the cornea using osmosis, temporarily reducing swelling and improving clarity. They are most effective when used consistently, often multiple times throughout the day.
These drops do not address the underlying cell failure and will not restore full vision long term. However, they can provide meaningful relief and help patients manage day-to-day while a surgical plan is considered.
Preservative-free lubricating eye drops help keep the corneal surface moist and protected, which can ease discomfort from a disrupted surface. Applying a warm, damp cloth to closed eyelids in the morning can also help reduce early-day blur caused by overnight fluid accumulation.
Keeping indoor air moist with a humidifier, especially during winter months, and wearing sunglasses outdoors to reduce light sensitivity are helpful additions to a daily management routine.
A soft bandage contact lens placed on the eye acts as a physical shield over the corneal surface, protecting exposed nerves from air and friction when a blister ruptures. This can significantly reduce the intensity and duration of pain episodes.
Bandage lenses are typically used alongside antibiotic drops to lower the risk of infection through any surface breaks. They are a bridge treatment, providing comfort while the patient prepares for or awaits surgery. Most patients use a bandage lens for weeks to months at a time.
Surgical Treatment for Bullous Keratopathy
Surgery is the only way to address the underlying cause of bullous keratopathy, and for many patients it offers the best chance of restoring clear, comfortable vision. Our Cornea Specialists at Rhode Island Eye Institute are experienced in the full range of surgical options for this condition.
Descemet Membrane Endothelial Keratoplasty, known as DMEK, is a partial-thickness corneal transplant that replaces only the failed endothelial cell layer with a paper-thin donor layer. Because only the diseased tissue is replaced, the rest of the patient's cornea remains intact.
DMEK offers the fastest visual recovery and the sharpest potential final vision of any corneal transplant technique. It also has lower rates of rejection compared to older transplant methods. Our Cornea Specialists, including Dr. Jane Cook and Dr. Elliot Perlman, perform this procedure for appropriate candidates.
Descemet Stripping Automated Endothelial Keratoplasty, or DSAEK, is a similar partial-thickness transplant that includes a slightly thicker layer of donor tissue. It is technically easier to handle than DMEK and may be preferred for eyes with unusual anatomy, prior surgery, or other complicating factors.
Visual recovery with DSAEK is excellent, though it may be somewhat slower than with DMEK. Your Cornea Specialist will evaluate your eye carefully and recommend the technique most likely to give you the best outcome.
Penetrating keratoplasty, or PK, is a full-thickness corneal transplant in which the entire cornea is replaced with donor tissue. This approach is typically reserved for cases where both the endothelium and the front layers of the cornea are severely damaged or scarred.
PK has a longer recovery period than DMEK or DSAEK, and stitches remain in place for many months following surgery. However, it remains the best option when the outer corneal layers cannot be preserved. Our team will help you understand whether a partial or full transplant is appropriate for your situation.
In rare cases where an eye has no usable vision but causes significant ongoing pain, the treatment goal shifts from restoration to comfort. Procedures such as a conjunctival flap (a Gundersen flap), in which a thin layer of tissue is drawn over the cornea, can protect the surface and eliminate blister-related pain.
These procedures do not restore sight. Your Cornea Specialist will only discuss palliative options when vision cannot be recovered and quality of life is being significantly affected by pain.
What to Expect During Recovery and Long-Term Care
Whether you are managing bullous keratopathy with drops and lenses or recovering from a corneal transplant, ongoing care and attention to warning signs make a meaningful difference in outcomes.
After an endothelial transplant, it is essential to use prescribed steroid eye drops exactly as directed. These drops reduce the immune response that can lead to graft rejection. Missing doses or stopping drops early is one of the most common reasons grafts fail.
Avoid rubbing the eyes, particularly in the early weeks after surgery. Protective eyewear may be recommended for activities that could put the eye at risk. Many patients are able to return to most normal activities within weeks, with vision continuing to improve over several months.
Corneal graft rejection can occur at any point after surgery, even years later. The most important thing to understand is that rejection caught early can almost always be treated successfully with intensive steroid drops. Delayed treatment significantly increases the risk of graft failure.
Contact your Cornea Specialist urgently if you notice any of the following after a transplant: new redness, increased light sensitivity, eye pain, or a sudden drop in vision. These four symptoms together are sometimes called the rejection warning signs, and acting quickly can save the graft.
Many corneal transplants last a decade or longer, and some last for many decades. Over time, donor endothelial cells naturally decline, and a small percentage of patients may eventually need a repeat transplant. Your Cornea Specialist will monitor your graft with regular specular microscopy imaging to track cell counts and catch any early signs of graft stress.
The timing of surgery is a personal decision made in partnership with your Cornea Specialist. Some patients choose to move forward when morning blur and pain start affecting their daily routine. Others wait until vision drops to a level that limits work, driving, or other important activities.
There is no single correct timeline. What matters most is that you have a clear understanding of your options, the likely outcomes, and the risks of waiting. Our team will give you the information you need to make a confident, informed choice.
Frequently Asked Questions
These answers address common questions and decision points that patients often raise when first learning about bullous keratopathy and their treatment options.
Hypertonic drops and lubricants are effective tools for short-term symptom relief, but they do not replace lost endothelial cells or stop further cell loss. Most patients find that drops become less effective as the condition progresses. If your daily life is being affected by pain or vision loss, it may be time to discuss surgical options with your Cornea Specialist, even if drops are still providing some benefit.
Modern endothelial transplants such as DMEK and DSAEK are well-established procedures with strong safety records. As with any surgery, there are risks, including infection, graft rejection, and incomplete attachment of the donor tissue. Your surgeon will review your individual risk profile before recommending a procedure. For most patients with bullous keratopathy, the potential benefit to vision and quality of life outweighs these risks significantly.
Yes, and it commonly does, particularly when the underlying cause is Fuchs endothelial dystrophy, which affects both eyes due to its genetic nature. The two eyes may progress at different rates, so one eye may require treatment sooner than the other. When the cause is pseudophakic bullous keratopathy after cataract surgery, it may be limited to only the operated eye, depending on the circumstances of that specific surgery.
In the first one to two days after DMEK, patients are often asked to spend significant time lying face-up to allow the thin donor tissue to attach properly to the back of the cornea. Activities are restricted during this period, and driving is not possible immediately after surgery. Vision typically begins to improve within days to weeks, with continued improvement over several months. Most patients can return to light daily activities fairly quickly, though your surgeon will give you specific guidance based on your case.
Candidacy depends on several factors, including the underlying cause of your bullous keratopathy, the condition of the rest of your eye, your overall health, and your vision goals. A thorough examination with corneal imaging and cell counting will give your Cornea Specialist the information needed to recommend the most appropriate surgical approach. Patients with other significant eye disease, such as advanced glaucoma or retinal conditions, may require additional evaluation before surgery.
Driving safety depends entirely on your current level of visual function. If your vision has dropped below your state's minimum legal standard for driving, it is not safe or legal to drive, and you should avoid it until your vision is evaluated and documented by your eye care provider. After a successful corneal transplant, many patients regain enough vision to drive again, though this varies by individual and by how much the condition had progressed before surgery.
Expert Corneal Care in Rhode Island
Rhode Island Eye Institute is home to a team of fellowship-trained Cornea Specialists, including Dr. Jane Cook, Dr. Elliot Perlman, and Dr. Christopher Newton, who bring decades of combined experience and academic expertise to the care of patients with bullous keratopathy and other corneal conditions. From your first evaluation to long-term follow-up care after surgery, our team is committed to giving you clear answers, personalized treatment options, and the highest level of corneal care available in the region. If you are experiencing morning blur, eye pain, or light sensitivity, we encourage you to schedule a consultation so we can evaluate your cornea and help you take the next step toward better vision and comfort.